Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure

Journal of Lipid Research

Volumn 48, Issue 7, 2007, Pages 1559-1570

  Sparagna, Genevieve C ^a   Chicco, Adam J ^a   Murphy, Robert C ^b   Bristow, Michael R ^c   Johnson, Christopher A ^b   Rees, Meredith L ^a   Maxey, Melissa L ^a   McCune, Sylvia A ^a   Moore, Russell L ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Aging; Cardiomyopathy; Congestive heart failure; Cytochrome oxidase; Linoleic acid; Mitochondria; Phospholipids

Indexed keywords

CARDIOLIPIN; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; TETRALINOLEOYL CARDIOLIPIN; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; EXPLANT; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFESPAN; LIPID ANALYSIS; MALE; MAMMAL; MITOCHONDRION; MORPHOLOGY; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SARCOLEMMA; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; SPRAGUE DAWLEY RAT;

ADULT; AGED; AGING; ANIMALS; CARDIOLIPINS; CITRATE (SI)-SYNTHASE; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, HEART; MYOCARDIUM; RATS; RATS, INBRED BN; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY;

EID: 34548167605     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600551-JLR200     Document Type: Article

References (65)

1. Ingwall, J. S., and R. G. Weiss. 2004. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 95: 135-145.
2. Quigley, A. F., R. M. Kapsa, D. Esmore, G. Hale, and E. Byrne. 2000. Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy. J. Card. Fail. 6: 47-55.
3. Buchwald, A., H. Till, C. Unterberg, R. Oberschmidt, H. R. Figulla, and V. Wiegand. 1990. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur. Heart J. 11: 509-516.
4. Garnier, A., D. Fortin, C. Delomenie, I. Momken, V. Veksler, and R. Ventura-Clapier. 2003. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551: 491-501.
5. Sharov, V. G., A. V. Todor, N. Silverman, S. Goldstein, and H. N. Sabbah. 2000. Abnormal mitochondrial respiration in failed human myocardium. J. Mol. Cell. Cardiol. 32: 2361-2367.
6. Hoppel, C. L., B. Tandler, W. Parland, J. S. Turkaly, and L. D. Albers. 1982. Hamster cardiomyopathy. A defect in oxidative phosphorylation in the cardiac interfibrillar mitochondria. J. Biol. Chem. 257: 1540-1548.
7. Beer, M., T. Seyfarth, J. Sandstede, W. Landschutz, C. Lipke, H. Kostler, M. von Kienlin, K. Harre, D. Hahn, and S. Neubauer. 2002. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 40: 1267-1274.
8. Liao, R., L. Nascimben, J. Friedrich, J. K. Gwathmey, and J. S. Ingwall. 1996. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ. Res. 78: 893-902.
9. Schlame, M., D. Rua, and M. L. Greenberg. 2000. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39: 257-288.
10. Schlame, M., M. Ren, Y. Xu, M. L. Greenberg, and I. Haller. 2005. Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids. 138: 38-49.
11. Hoch, F. L. 1992. Cardiolipins and biomembrane function. Biochim. Biophys. Acta. 1113: 71-133.
12. Schlame, M., and D. Otten. 1991. Analysis of cardiolipin molecular species by high-performance liquid chromatography of its derivative 1,3-bisphosphatidyl-2-benzoyl-sn-glycerol dimethyl ester. Anal. Biochem. 195: 290-295.
13. Yamaoka, S., R. Urade, and M. Kito. 1988. Mitochondrial function in rats is affected by modification of membrane phospholipids with dietary sardine oil. J. Nutr. 118: 290-296.
14. Yamaoka, S., R. Urade, and M. Kito. 1990. Cardiolipin molecular species in rat heart mitochondria are sensitive to essential fatty acid-deficient dietary lipids. J. Nutr. 120: 415-421.
15. Xu, Y., A. Malhotra, M. Ren, and M. Schlame. 2006. The enzymatic function of tafazzin. J. Biol. Chem. 281: 39217-39224.
16. Xu, Y., R. I. Kelley, T. J. Blanck, and M. Schlame. 2003. Remodeling of cardiolipin by phospholipid transacylation. J. Biol. Chem. 278: 51380-51385.
17. Hauff, K. D., and G. M. Hatch. 2006. Cardiolipin metabolism and Barth syndrome. Prog. Lipid Res. 45: 91-101.
18. McKenzie, M., M. Lazarou, D. R. Thorburn, and M. T. Ryan. 2006. Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J. Mol. Biol. 361: 462-469.
19. Ma, L., F. M. Vaz, Z. Gu, R. J. Wanders, and M. L. Greenberg. 2004. The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome. J. Biol. Chem. 279: 44394-44399.
20. Schlame, M., and M. Ren. 2006. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 580: 5450-5455.
21. Chicco, A. J., and G. C. Sparagna. 2007. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am. J. Physiol. Cell Physiol. 292: C33-C44.
22. Paradies, G., F. M. Ruggiero, G. Petrosillo, and E. Quagliariello. 1997. Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett. 406: 136-138.
23. Lesnefsky, E. J., T. J. Slabe, M. S. Stoll, P. E. Minkler, and C. L. Hoppel. 2001. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am. J. Physiol. Heart Circ. Physiol. 280: H2770-H2778.
24. Paradies, G., F. M. Ruggiero, P. Dinoi, G. Petrosillo, and E. Quagliariello. 1993. Decreased cytochrome oxidase activity and changes in phospholipids in heart mitochondria from hypothyroid rats. Arch. Biochem. Biophys. 307: 91-95.
25. Schlame, M., J. A. Towbin, P. M. Heerdt, R. Jehle, S. DiMauro, and T. J. Blanck. 2002. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neurol. 51: 634-637.
26. Vreken, P., F. Valianpour, L. G. Nijtmans, L. A. Grivell, B. Plecko, R. J. Wanders, and P. G. Barth. 2000. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279: 378-382.
27. Sparagna, G. C., C. A. Johnson, S. A. McCune, R. L. Moore, and R. C. Murphy. 2005. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J. Lipid Res. 46: 1196-1204.
28. Lee, H. J., J. Mayette, S. I. Rapoport, and R. P. Bazinet. 2006. Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis. 5: 2.
29. Savitha, S., and C. Panneerselvam. 2006. Mitochondrial membrane damage during aging process in rat heart: potential efficacy of L carnitine and DL alpha lipoic acid. Mech. Ageing Dev. 127: 349-355.
30. Paradies, G., F. M. Ruggiero, G. Petrosillo, and E. Quagliariello. 1993. Age-dependent decrease in the cytochrome c oxidase activity and changes in phospholipids in rat-heart mitochondria. Arch. Gerontol. Geriatr. 16: 263-272.
31. Heyen, J. R., E. R. Blasi, K. Nikula, R. Rocha, H. A. Daust, G. Frierdich, J. F. Van Vleet, P. De Ciechi, E. G. McMahon, and A. E. Rudolph. 2002. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am. J. Physiol. Heart Circ. Physiol. 283: H1775-H1784.
32. Palmer, J. W., B. Tandler, and C. L. Hoppel. 1977. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J. Biol. Chem. 252: 8731-8739.
33. Fannin, S. W., E. J. Lesnefsky, T. J. Slabe, M. O. Hassan, and C. L. Hoppel. 1999. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch. Biochem. Biophys. 372: 399-407.
34. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
35. Lesnefsky, E. J., B. Tandler, J. Ye, T. J. Slabe, J. Turkaly, and C. L. Hoppel. 1997. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am. J. Physiol. 273: H1544-H1554.
36. Srere, P. 1969. Citrate synthase. Methods Enzymol. 13: 3-5.
37. Emter, C. A., S. A. McCune, G. C. Sparagna, M. J. Radin, and R. L. Moore. 2005. Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats. Am. J. Physiol. Heart Circ. Physiol. 289: H2030-H2038.
38. Lehnart, S. E., W. Schillinger, B. Pieske, J. Prestle, H. Just, and G. Hasenfuss. 1998. Sarcoplasmic reticulum proteins in heart failure. Ann. N. Y. Acad. Sci. 853: 220-230.
39. Pacher, P., J. G. Mabley, L. Liaudet, O. V. Evgenov, A. Marton, G. Hasko, M. Kollai, and C. Szabo. 2004. Left ventricular pressurevolume relationship in a rat model of advanced aging-associated heart failure. Am. J. Physiol. Heart Circ. Physiol. 287: H2132-H2137.
40. Lipman, R. D., C. E. Chrisp, D. G. Hazzard, and R. T. Bronson. 1996. Pathologic characterization of Brown Norway, Brown Norway X Fischer 344, and Fischer 344 X Brown Norway rats with relation to age. J. Gerontol. A Biol. Sci. Med. Sci. 51: B54-B59.
41. Walker, E. M., Jr., M. S. Nillas, E. I. Mangiarua, S. Cansino, R. G. Morrison, R. R. Perdue, W. E. Triest, G. L. Wright, M. Studeny, P. Wehner, et al. 2006. Age-associated changes in hearts of male Fischer 344/Brown Norway F1 rats. Ann. Clin. Lab. Sci. 36: 427-438.
42. O'Rourke, B., and D. K. Reibel. 1992. Effects of adrenoceptor blockade on cardiac hypertrophy and myocardial phospholipids. Proc. Soc. Exp. Biol. Med. 200: 95-100.
43. Reibel, D. K., B. O'Rourke, K. A. Foster, H. Hutchinson, C. E. Uboh, and R. L. Kent. 1986. Altered phospholipid metabolism in pressure-overload hypertrophied hearts. Am. J. Physiol. 250: H1-H6.
44. Heerdt, P. M., M. Schlame, R. Jehle, A. Barbone, D. Burkhoff, and T. J. Blanck. 2002. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann. Thorac. Surg. 73: 1216-1221.
45. Stanley, W. C., F. A. Recchia, and G. D. Lopaschuk. 2005. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85: 1093-1129.
46. Ventura-Clapier, R., A. Garnier, and V. Veksler. 2004. Energy metabolism in heart failure. J. Physiol. 555: 1-13.
47. Kelly, D. P., and A. W. Strauss. 1994. Inherited cardiomyopathies. N. Engl. J. Med. 330: 913-919.
48. Hansson, A., N. Hance, E. Dufour, A. Rantanen, K. Hultenby, D. A. Clayton, R. Wibom, and N. G. Larsson. 2004. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc. Natl. Acad. Sci. USA. 101: 3136-3141.
49. Li, Y. Y., D. Chen, S. C. Watkins, and A. M. Feldman. 2001. Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity. Circulation. 104: 2492-2497.
50. Ide, T., H. Tsutsui, S. Hayashidani, D. Kang, N. Suematsu, K. Nakamura, H. Utsumi, N. Hamasaki, and A. Takeshita. 2001. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 88: 529-535.
51. Arbustini, E., M. Diegoli, R. Fasani, M. Grasso, P. Morbini, N. Banchieri, O. Bellini, B. Dal Bello, A. Pilotto, G. Magrini, et al. 1998. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am. J. Pathol. 153: 1501-1510.
52. Yamaoka-Koseki, S., R. Urade, and M. Kito. 1991. Cardiolipins from rats fed different dietary lipids affect bovine heart cytochrome c oxidase activity. J. Nutr. 121: 956-958.
53. Zhang, M., E. Mileykovskaya, and W. Dowhan. 2002. Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J. Biol. Chem. 277: 43553-43556.
54. Pfeiffer, K., V. Gohil, R. A. Stuart, C. Hunte, U. Brandt, M. L. Greenberg, and H. Schagger. 2003. Cardiolipin stabilizes respiratory chain supercomplexes. J. Biol. Chem. 278: 52873-52880.
55. Paradies, G., G. Petrosillo, and F. M. Ruggiero. 1997. Cardiolipin-dependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim. Biophys. Acta. 1319: 5-8.
56. Paradies, G., F. M. Ruggiero, G. Petrosillo, and E. Quagliariello. 1998. Peroxidative damage to cardiac mitochondria: cytochrome oxidase and cardiolipin alterations. FEBS Lett. 424: 155-158.
57. Bione, S., P. D'Adamo, E. Maestrini, A. K. Gedeon, P. A. Bolhuis, and D. Toniolo. 1996. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat. Genet. 12: 385-389.
58. Schlame, M., R. I. Kelley, A. Feigenbaum, J. A. Towbin, P. M. Heerdt, T. Schieble, R. J. Wanders, S. DiMauro, and T. J. Blanck. 2003. Phospholipid abnormalities in children with Barth syndrome. J. Am. Coll. Cardiol. 42: 1994-1999.
59. Xu, Y., A. Malhotra, M. Ren, and M. Schlame. 2006. The enzymatic function of tafazzin. J. Biol. Chem. 281: 39217-39224.
60. McMillin, J. B., G. E. Taffet, H. Taegtmeyer, E. K. Hudson, and C. A. Tate. 1993. Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovasc. Res. 27: 2222-2228.
61. 2+ activation of PDH. Am. J. Physiol. 276: H149-H158.
62. Moghaddas, S., M. S. Stoll, P. E. Minkler, R. G. Salomon, C. L. Hoppel, and E. J. Lesnefsky. 2002. Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria. J. Gerontol. A Biol. Sci. Med. Sci. 57: B22-B28.
63. Kajstura, J., W. Cheng, R. Sarangarajan, P. Li, B. Li, J. A. Nitahara, S. Chapnick, K. Reiss, G. Olivetti, and P. Anversa. 1996. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am. J. Physiol. 271: H1215-H1228.
64. Sample, J., J. G. Cleland, and A. M. Seymour. 2006. Metabolic remodeling in the aging heart. J. Mol. Cell. Cardiol. 40: 56-63.
65. Iemitsu, M., T. Miyauchi, S. Maeda, T. Tanabe, M. Takanashi, Y. Irukayama-Tomobe, S. Sakai, H. Ohmori, M. Matsuda, and I. Yamaguchi. 2002. Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training. Am. J. Physiol. Heart Circ. Physiol. 283: H1750-H1760.